Please login to the form below

Not currently logged in
Email:
Password:

Insmed appoints FDA's Dr Eugene Sullivan

He joinsthe US biopharmaceutical firm as its chief medical officer

US biopharmaceutical company Insmed has appointed former deputy director of the FDA Dr Eugene Sullivan to be its new chief medical and scientific officer.

Dr Sullivan was most recently vice president of global regulatory affairs at AstraZeneca and prior to that, during a career that has so far spanned more than 20 years focusing on pulmonary and orphan diseases, served at United Therapeutics.

He also spent a seven-year spell from 1999 at the FDA, where he held several positions, including deputy director of its Pulmonary and Allergy Products division.

In his new role Dr Sullivan will report to Will Lewis, president and chief executive officer, who said: “Gene is actively involved as an author, lecturer and advisor on medical and regulatory matters affecting orphan drugs and pulmonary diseases.

“His experience will provide new insight and valuable perspective as we advance Arikayce, INS1009 and our other pipeline candidates while building Insmed into a leading biopharmaceutical company.”

30th March 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics